Why weight loss feels slow on Mounjaro — and what's actually happening

Weight loss on Mounjaro typically slows after the initial weeks, this is physiologically normal, not a sign of failure.
Dose, lifestyle factors and individual biology all influence the rate and extent of loss at any point in treatment.
Plateaus often precede renewed progress, particularly after a dose increase prescribed by your clinician.
If progress has stopped completely rather than slowed, that's worth discussing with your prescriber before drawing conclusions.

Weight loss on Mounjaro is rarely a straight line. If progress has slowed or stalled, that doesn't mean the medicine isn't working. Most people lose weight fastest in the first few weeks, then experience a natural plateau as the body adapts — a pattern well documented in the SURMOUNT-1 trial published in the New England Journal of Medicine. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber decides whether it's clinically appropriate for you, and any concerns about your progress are best raised with them directly.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What's really going on when Mounjaro stops feeling fast

The biggest myth: slow progress means the medicine isn't working

The most common worry our prescribers hear is some version of this: "I lost a stone in the first month and now I've barely lost a pound in three weeks, something must be wrong." It's an understandable conclusion. But it almost always reflects how the body responds to any sustained calorie deficit, not a failure of the medicine.

In the SURMOUNT-1 trial, participants lost weight steadily over 72 weeks, but the curve was steepest early on. As the body adjusts to a lower energy intake, it adapts, resting metabolic rate shifts, hormones that regulate hunger settle into a new pattern, and the dramatic early losses slow to something that feels, week to week, almost invisible. The scale isn't lying. The process has just moved into a different gear.

Tirzepatide, the active ingredient in Mounjaro, works by activating both GIP and GLP-1 receptors, reducing appetite and slowing gastric emptying. Those effects don't switch off during a plateau; the body is still responding, just differently. You can read more about how the medicine works on our tirzepatide overview page.

Four reasons weight loss on Mounjaro can slow down

Understanding the cause of a slowdown makes it far less frightening. There are a handful of common explanations worth knowing about.

Dose and titration. Treatment starts at 2.5mg, a dose chosen to let the body settle rather than to drive weight loss at full intensity. Progress at that strength is often modest. As the prescriber increases the dose in line with your tolerance, most people find the pace picks up again. If you're wondering whether this slowdown is expected at your current dose, the short answer is often yes.

Metabolic adaptation. The body is remarkably good at defending its weight. As fat stores fall, lean mass can dip too, which lowers the number of calories you burn at rest. This isn't unique to Mounjaro; it happens with any sustained weight loss. Protein intake and resistance activity can help preserve muscle mass during treatment, though your prescriber or a dietitian is the right person to guide specifics.

Lifestyle factors. Mounjaro suppresses appetite significantly for most people, but what you eat when hunger is low still matters. Highly processed foods, inconsistent sleep and low physical activity can all slow the rate of loss even when the medicine is doing its job. The NHS healthy weight guidance offers a useful starting point on supporting lifestyle changes alongside treatment.

Natural plateau biology. Some slowdowns are simply the body pausing. Weight often drops in steps rather than a smooth slope, a period of little movement followed by a shift. Tracking weight over a longer window (monthly rather than weekly) often tells a more reassuring story than the day-to-day number.

When slow weight loss becomes something to act on

There's a clinical benchmark worth knowing: NICE guidance on tirzepatide (TA1026) indicates that if someone loses less than 5% of their body weight after six months at the highest tolerated dose, continuing treatment should be reviewed. That's a six-month, highest-tolerated-dose threshold, not a signal to panic at a slow fortnight.

Still, if your weight loss has completely stopped for several weeks rather than just slowed, it's sensible to raise it with your prescriber. They can review whether your dose is optimised, whether anything else is affecting progress, and whether the treatment is still right for you at this stage. You can find a fuller breakdown of what to do when progress has stalled on our page about weight loss stopping on Mounjaro.

It's also worth knowing that some people find the pattern of loss differs between doses. Our page on slow weight loss on Mounjaro covers this in more depth, and you can compare typical results across the treatment journey on our Mounjaro weight loss results page.

What to do while you wait for progress to resume

The most useful thing is usually to keep doing what's working and give the medicine time. Keep your injection day consistent, rotate sites between abdomen, thigh and upper arm as your Patient Information Leaflet advises, and focus on the habits (regular movement, adequate protein, good hydration) that support the medicine rather than substitute for it.

If cost or treatment continuity is on your mind alongside progress, it's worth reading about how UK Mounjaro pricing has changed so there are no surprises. And if you'd like a prescriber to review your progress properly, the most direct route is a consultation. At nume, every repeat order is reviewed by a named clinician before anything is dispensed, not a checklist, a real clinical read. If you'd like to check your eligibility or discuss where you are in your treatment, that's where to start.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions